DONATE

IBEC Seminar: Andela Saric

How to build a biological nanomachine Andela Saric , University College London The molecular machinery of life is largely created via self-organisation of individual molecules into functional larger-scaled structures. Such … Read more

IBEC Seminar: Marc Vendrell

Translational chemistry, optical imaging and precision medicine Marc Vendrell , University of Edinburgh Optical imaging has revolutionised our understanding of how biological systems behave at the molecular level. In the … Read more

IBEC Seminar: Andela Saric

How to build a biological nanomachine Andela Saric , University College London The molecular machinery of life is largely created via self-organisation of individual molecules into functional larger-scaled structures. Such … Read more

IBEC Seminar: Andela Saric

How to build a biological nanomachine Andela Saric , University College London The molecular machinery of life is largely created via self-organisation of individual molecules into functional larger-scaled structures. Such … Read more

HealthTech World Cancer Day 2020 “Smarter technologies to beat cancer!”

La Plataforma Española de Nanomedicina coordinada por el IBEC (NanoMed Spain) coorganiza la séptima edición del Health TECH World Cancer Day, una iniciativa mundial organizada como parte del Día Mundial del Cáncer. Este es el quinto año consecutivo que la plataforma acoge la conferencia, que se celebrará en la Sala Pau Viladiu de l’Hospital Duran i Reynals el próximo 3 de febrero. La inauguración irá a cargo de Josep Samitier (Coordinador Científico de NANOMED Spain y Director del Institut de Bioenginyeria de Catalunya) e Isabel Fabregat (Coordinadora del Programa de Mecanismos Moleculares y Terapia Experimental en Oncología e Investigadora en IDIBELL).

Nuevos avances en la mejora del diseño de fármacos contra la taupatía globular glial

José Antonio del Río, investigador principal en el Instiuto de Bioingeniería de Cataluña (IBEC) junto con el Dr. Isidre Ferrer del Instituto de Investigaciones Biomédicas de Bellvitge (IDIBELL) han liderado un estudio en el que han descubierto que la patología que muestran los pacientes con taupatia globular glial es debida a la generación de depósitos proteicos dañinos para las neuronas y las células gliales.

Postdoc researcher at the Molecular and Cellular Neurobiotechnology Research Group


Application Deadline: 10/02/2020
Ref: PD-AH

The The Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral researcher to develop a research project on new strategies for the treatment of spinal cord injuries. The contract will be within the framework of Severo Ochoa program, whose objective is to promote excellence in the research institute.

Funding Technician at the Projects Office

Application Deadline: 14/02/2020
Ref: FT_JA

We are looking for a Funding Technician who will play a critical role in the overall post-award support and project administrative management to Projects office.